Adjuvant and neoadjuvant therapy in prostate cancer

被引:18
作者
Chay, C [1 ]
Smith, DC [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
关键词
D O I
10.1053/sonc.2001.20744
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3 / 12
页数:10
相关论文
共 44 条
  • [1] Adib RS, 1997, BRIT J UROL, V79, P235
  • [2] Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
    Albertsen, PC
    Hanley, JA
    Gleason, DF
    Barry, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 975 - 980
  • [3] Andriole GL, 1997, EUR UROL, V32, P65
  • [4] [Anonymous], 1992, Lancet, V339, P1
  • [6] MULTIVARIATE-ANALYSIS OF FACTORS PREDICTING LOCAL RELAPSE AFTER RADICAL PROSTATECTOMY - POSSIBLE INDICATIONS FOR POSTOPERATIVE RADIOTHERAPY
    ANSCHER, MS
    PROSNITZ, LR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (04): : 941 - 947
  • [7] Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
    Bolla, M
    Gonzalez, D
    Warde, P
    Dubois, JB
    Mirimanoff, RO
    Storme, G
    Bernier, J
    Kuten, A
    Sternberg, C
    Gil, T
    Collette, L
    Pierart, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) : 295 - 300
  • [8] Byar D P, 1988, NCI Monogr, P165
  • [9] BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
  • [10] 2-C